Immune checkpoint inhibitor-associated diabetes mellitus: an overlooked immune-related adverse event-two case reports and a literature review.

Saved in:
Bibliographic Details
Title: Immune checkpoint inhibitor-associated diabetes mellitus: an overlooked immune-related adverse event-two case reports and a literature review.
Authors: He M; Department of Oncology, Hebei General Hospital, Shijiazhuang, China.; Graduate School, Hebei Medical University, Shijiazhuang, China., Zheng Z; Department of Oncology, Hebei General Hospital, Shijiazhuang, China., Guo X; Department of Oncology, Hebei General Hospital, Shijiazhuang, China., Cheng G; Department of Oncology, Hebei General Hospital, Shijiazhuang, China., Zhang S; Department of Oncology, Hebei University of Chinese Medicine Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, China., Liu J; Department of Oncology, Hebei General Hospital, Shijiazhuang, China.; Graduate School, Hebei North University, Zhangjiakou, China., Zhao J; Department of Oncology, Hebei General Hospital, Shijiazhuang, China.
Source: Frontiers in immunology [Front Immunol] 2026 May 08; Vol. 17, pp. 1831879. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).
Publication Type: Journal Article; Case Reports; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1831879